Photo of successful group of business people

Last updated: Nov 6, 2025


HBW Insight spotlights regulatory affairs specialists in the consumer health and cosmetics industries. Discover what their roles entail, a typical day’s challenges, and what’s top of mind for them.


Foreword

Change and complexity define the role of regulatory affairs specialists within the consumer health care and cosmetics industries, according to the interviews collected here in this HBW Insight ‘Inside Regulatory Affairs’ ebook.

In general, we are seeing increased regulation in two of the biggest global markets, the US and in Europe, driven in large part by an expectation that industry should take more responsibility in looking after the planet, as well as the health and well-being of its inhabitants.

Multiple regulations proceeding from the EU Green Deal, for example, ask companies to ensure that products are not just safe to use, but also to dispose of and, if possible, reuse.

While they can be anxiety-producing, these changing demands also stimulate creativity and new ways of thinking and feed the hunger for new challenges that seem to characterize the profession.

As well as a love of learning, the ability to collaborate with internal teams and external stakeholders, including regulatory authorities, is crucial to the success of today’s regulatory professionals. Trade associations provide an essential bridge between worlds, our interviews show.

We hope you find value in this series highlighting an increasingly vital and, we think, undercelebrated role in consumer health and cosmetics organizations and one that HBW Insight aims to serve consistently with our news and analysis.

Look for future series at HBW Insight providing insight into key topics and trends of importance to our audience and, if you haven’t already, subscribe today.


Download eBook

Related resources

''
Clinical

Pharma R&D Annual Review 2024

For over 30 years, the Pharma R&D Annual Review has tracked how the climate is shifting. Browse our resources to help you navigate the climate.

Citeline professional presenting the Q3 2024 Outlook Report provided by Biomedtracker.
JUL 08, 2024
Report
Commercial

Q3 2024 Outlook Report

In this report, we cover catalysts from 24 drugs, devices, diagnostics, and deals expected to occur in Q3 2024.

Stacks of coins arranged in ascending order with a white arrow and line graph overlay indicating growth
JUN 11, 2024
eBook
Commercial

Billion Dollar Blueprint: The Journey to Blockbuster Status

The industry’s top-selling drugs generate billions in revenues each year. Scrip analyzed data on nearly 200 blockbuster drugs, in search of the secret formula for creating the next pharmaceutical behemoth.